Big Data Powers Design of ‘Smart’ Cell Therapies for Cancer
Finding medicines that can kill cancer cells while leaving normal tissue unscathed is a Holy Grail of oncology research.
University of California San Francisco
Give to UCSFFinding medicines that can kill cancer cells while leaving normal tissue unscathed is a Holy Grail of oncology research.
The John and Marcia Goldman Foundation, a private family foundation based in San Francisco, recently granted The Kidney Project $1 million to advance its bioartificial kidney.
UCSF scientists have devised a novel approach to halting the spread of SARS-CoV-2, the virus that causes the disease.
As the United States’ testing regime floundered early in the pandemic, scientists at UCSF and the Chan Zuckerberg Biohub created from scratch a diagnostic lab that became a model for the nation.
Joel Ernst, MD, addresses key questions about how vaccine development works and why vaccines are especially important in the case of COVID-19.
While the widely used coronavirus PCR tests take about four hours to produce a result from a respiratory sample, the new DETECTR test developed by UCSF scientists takes only 45 minutes, rapidly accelerating the pace of diagnosis.
We are entering an era of brain-machine interfaces and genome-editing technology. When we can govern the very biology that makes us who we are, what will it mean to be human?
No one can see the future, but that won’t stop us from trying. We asked UCSF faculty and alumni to score these predictions for likelihood and impact.
With the rise of “direct-to-consumer” DNA tests, investigating your genes is easier than ever. But taking one of these tests may not be right for you, says UCSF professor Kathryn Phillips, PhD, who studies new health care technologies.
Ramani is featured for co-inventing sci-Plex, a new technique that enables high-throughput chemical screening using single-cell RNA-sequencing as a read-out.
After phages infect bacteria, they construct an impenetrable “safe room” inside of their host, which protects vulnerable phage DNA from antiviral enzymes. This compartment, which resembles a cell nucleus, is the most effective CRISPR shield ever discovered in viruses.
With a $106 million gift from the Weill Family Foundation, UC Berkeley, UC San Francisco, and the University of Washington have launched the Weill Neurohub to speed the development of new therapies for diseases and disorders that affect the brain and nervous system.
UCSF is launching a new center to accelerate the application of AI technology to radiology.